Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi | Paris | Healthcare | Pharmaceuticals | €98.69B | 15.7x | 0.13 | €80.93 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.9% Upside | Upgrade to Pro+ | |
Ipsen | Paris | Healthcare | Pharmaceuticals | €8.77B | 19.5x | -0.57 | €106.30 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.8% Upside | Upgrade to Pro+ | |
Virbac | Paris | Healthcare | Pharmaceuticals | €2.78B | 19.1x | 0.93 | €331.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.2% Upside | Upgrade to Pro+ | |
Vetoquinol | Paris | Healthcare | Pharmaceuticals | €877.60M | 15x | 2.51 | €74.40 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.3% Upside | Upgrade to Pro+ | |
Medincell | Paris | Healthcare | Pharmaceuticals | €528.61M | €15.98 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37.7% Upside | Upgrade to Pro+ | |||
Boiron | Paris | Healthcare | Pharmaceuticals | €368.95M | 32.2x | -0.48 | €21.25 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.6% Upside | Upgrade to Pro+ | |
Euroapi | Paris | Healthcare | Pharmaceuticals | €281.68M | -2.1x | -0.04 | €2.96 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.4% Upside | Upgrade to Pro+ | |
DBV Technologies | Paris | Healthcare | Pharmaceuticals | €237.42M | -1.8x | 0.1 | €1.74 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -12.6% Downside | Upgrade to Pro+ | |
AB Science | Paris | Healthcare | Pharmaceuticals | €93.21M | -9.1x | -0.32 | €1.34 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SMAIO | Paris | Healthcare | Pharmaceuticals | €43.03M | -9.6x | 0.05 | €7.65 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.5% Downside | Upgrade to Pro+ | |
Nicox | Paris | Healthcare | Pharmaceuticals | €38.20M | -0.6x | €0.53 | -15.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Aelis Farma | Paris | Healthcare | Pharmaceuticals | €17.74M | -2.3x | 0.06 | €1.31 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Advicenne | Paris | Healthcare | Pharmaceuticals | €16.80M | -1.5x | -0.14 | €1.19 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Valerio Therapeutics | Paris | Healthcare | Pharmaceuticals | €11.81M | -0.4x | 0.08 | €0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |